An Update on Common Chromosome Microdeletion and Microduplication Syndromes

Area of Science:

• Genetics
• Pediatrics
• Medical Diagnostics

Background:

• Microdeletion and microduplication syndromes are genetic disorders affecting chromosomal hotspots.
• These conditions, including 22q11.2, 7q11.23, 17p11.2, and 16p11.2, have varying prevalence rates.
• Associated risks include developmental delay, autism, congenital anomalies, and specific risks for schizophrenia or aortic conditions.

Purpose of the Study:

• To review common microdeletion and microduplication syndromes.
• To highlight updated patient-care needs for individuals with these conditions.
• To emphasize the diagnostic utility of chromosomal microarray analysis.

Main Methods:

• Review of current literature on microdeletion and microduplication syndromes.
• Analysis of patient-care updates and diagnostic approaches.
• Comparison of diagnostic capabilities of karyotyping versus chromosomal microarray analysis.

Main Results:

• Specific syndromes like 22q11.2 deletion/duplication and 7q11.23 deletion/duplication present distinct genetic risks.
• Many of these conditions are not detectable by standard karyotyping.
• Chromosomal microarray analysis (CMA) is a comprehensive screening tool for these disorders.

Conclusions:

• CMA enables timely diagnosis and appropriate management of microdeletion and microduplication syndromes.
• Understanding specific syndrome risks is vital for tailored patient care.
• Early and accurate diagnosis through CMA improves patient outcomes.